/EDIT

Editas Medicine Inc

EDIT

$2.70USD↑+1.89%+0.05 today

MARKET CAP

414.7M

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$3 – $3

52W RANGE

$2

$5

AI Summary

Stalk

StalkMedium

While the asset remains in a Stage 4 decline with a decisive support failure and lower-high/lower-low regime, mean-reversion conditions are present as near‐low forward P/E, elevated FCF yield, and price at a prior defended zone signal a potential counter‐trend opportunity. Short-term price is extended below declining EMAs without clear exhaustion, suggesting deferred entry. Execution should focus on stalking shallow pullbacks into the 9 EMA, 21 EMA, or the area just above the 200 DMA to participate in an anticipated mean-reversion.

↑Renicel Ruby trial: all patients free from vaso-occlusive events post-infusion.
↑Q2 2024 cash of $318M funds operations and R&D into 2026.
↓Q1 2024 revenue dropped to $1.1M versus $9.9M in Q1 2023.

Full analysis →

Buying

11

institutions

Selling

5

institutions

New Positions

7

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	10.59 M	34.31 M	+1.33 M	+50.0%	0.00%
AC Adar1 Capital Management, LLC Q2 2026	BUYNEW	8.89 M	28.80 M	+8.89 M	+0.0%	1.33%
RC Ra Capital Management, L.P. Q2 2026	BUYNEW	8.89 M	28.80 M	+8.89 M	+0.0%	0.25%
WP Woodline Partners LP Q2 2026	BUYNEW	3.56 M	11.52 M	+3.56 M	+0.0%	0.04%
RT Renaissance Technologies LLC Q2 2026	SELL	2.47 M	8.00 M	+-1.50 M	-18.5%	0.01%
JC Jpmorgan Chase & Co Q2 2026	SELL	1.86 M	5.96 M	+-84.89 K	+37.2%	0.00%
AC Aqr Capital Management LLC Q2 2026	BUY	1.57 M	5.09 M	+201.75 K	+50.5%	0.00%
MM Millennium Management LLC Q2 2026	BUYNEW	499.00 K	1.62 M	+499.00 K	+0.0%	0.00%
EP Eversept Partners, LP Q2 2026	BUY	458.81 K	1.49 M	+167.89 K	+106.9%	0.08%
CA Citadel Advisors LLC Q2 2026	SELL	455.66 K	1.48 M	+-420.13 K	-31.8%	0.00%
CC Casdin Capital, LLC Q2 2026	BUYNEW	445.00 K	1.44 M	+445.00 K	+0.0%	0.07%
PA Point72 Asset Management, L.P. Q2 2026	BUY	125.23 K	405.76 K	+8.24 K	+40.4%	0.00%
BA Balyasny Asset Management L.P. Q2 2026	BUYNEW	37.64 K	121.95 K	+37.64 K	+0.0%	0.00%
RC Rockefeller Capital Management L.P. Q2 2026	SELL	22.46 K	72.79 K	+-575.00	+27.9%	0.00%
BH Brevan Howard Capital Management LP Q2 2026	BUYNEW	14.36 K	46.52 K	+14.36 K	+0.0%	0.00%
MG Man Group Plc Q2 2026	SELL	0.00	0.00	+-125.51 K	-100.0%	0.00%